EXPLORING ONCOLOGY

Exploring Oncology Practice

Oncology nurses are tasked with understanding all aspects of the oncology field and applying their knowledge to everyday practice. We live in a time when, fortunately, information is readily available, though sometimes, in abundance. Certifications are one of many ways to fulfill the lifelong learning requirements of many healthcare professions. The Oncology Nursing Certification Corporation (ONCC), founded by the distinguished ONS in 1984, provides opportunity for various certifications, and continuing education opportunities with the goal of enhancing specialized oncology knowledge to improve patient outcomes.

 

More Information from ONCC:

Why get certified? Click here for ONCC fast fact sheet

2019 ONQ Improvement Series Education Tracks/Topics

To meet oncology education needs, the symposia offered on the CME Activities link will include the following courses:

1) Considerations for Oncology Nurses—Individualizing the Management of Acute Myeloid Leukemia: Genomics, Targeted Therapeutic Options, and Treatment Sequencing

Learning Objectives:

  1. Review therapeutic targets in AML, including BCL-2, FLT3, IDH1, IDH2, CD33, and the Hedgehog pathway signaling
  2. Assess AML patients by risk categories based on cytogenetic and molecular information
  3. Describe current and novel therapeutic approaches for patients with previously untreated and relapsed/refractory AML
  4. Plan individualized treatment strategies of sequential and combination regimens for patients with AML by integrating new agents into the current treatment paradigm
  5. Discuss strategies that will improve communication, engagement, education, and decision making with AML patients and their healthcare providers

2) From the Nurses’ Perspective: Immuno-Oncology Treatment Options Shared Decision Making in Advanced NSCLC

Learning Objectives:

  1. Describe the mechanism of action of immune checkpoint inhibitors
  2. Evaluate clinical trial data on the efficacy and safety of immune checkpoint inhibitors in the treatment of NSCLC
  3. Recognize and manage immune-related adverse events associated with the use of immune checkpoint inhibitors
  4. Describe the fundamentals of shared decision-making and its utility in optimizing patient care in clinical practice

3) The Importance of the Nurse—Patient Interaction in Optimizing Treatment of Advanced Melanoma

Learning Objectives:

  1. Describe the factors contributing to underdiagnosis/misdiagnosis/late diagnosis of melanoma in addition to the underlying pathogenesis and associated cellular pathways that drive advanced melanoma
  2. Discuss the mechanism of action of available immunotherapies for the treatment of advanced melanoma
  3. Review current clinical trial data for immunotherapy agents in the treatment of advanced melanoma
  4. Review strategies for recognizing and managing immune-based therapy related toxicities and discuss proper methodologies to relay these strategies

4) The Oncology Nurse’s Role in the Management of Immunotherapy for Head and Neck Cancer

Learning Objectives:

  1. Describe the dysregulation of the immune system that supports the development of SCCHN
  2. Review the mechanisms of action of immune-oncology therapies in patients with recurrent and metastatic SCCHN
  3. Discuss clinical trial-derived efficacy and safety data for immuno-oncology agents for use in patients with recurrent or metastatic SCCHN
  4. Explain how to recognize and manage immune checkpoint inhibitor-associated immune-related adverse events in patients with SCCHN

5) The Use and Implementation of Targeted Therapy for Early HER2-positive Breast Cancer: An Expanding Role for Nurse

Learning Objectives:

  1. Describe the biological markers that characterize the pathologic assessment of HER2-positive breast cancer
  2. Explain currently available adjuvant treatment regimens for patients with HER2-positive breast cancer
  3. Review the emerging clinical trial data for dual anti-HER2 strategies with chemotherapy in the adjuvant setting
  4. Describe the role of nurses on the multidisciplinary care team for patients with breast cancer, and review ways to enhance care for early HER2-positive breast cancer